American Society for Radiation Oncology Annual Meeting (ASTRO)

Articles

This study found that found that mini-strokes and heart attacks were significantly less common among patients with locally advanced non-small cell lung cancer who underwent proton therapy versus conventional photon-based radiation therapy.

Proton Radiotherapy in Patients with LA-NSCLC May Aid in Reducing Risk of Heart Disease

In working patients with head and neck cancer receiving radiotherapy, weight loss and an increase in pain, fatigue, and ECOG status were all found to be significantly associated with reductions in working days per week.

Patients with Head and Neck Cancer See Impact on Ability to Work Due to Radiotherapy

This study suggested that the racial composition of clinical trials involving radiation therapy does not match that of the overall US population. 

Racial Composition of Trials Involving RT Does Not Match Overall US Population

A study presented at the ASTRO Annual Meeting found that adding the advanced PET radiotracer fluciclovine (Axumin) to conventional imaging for patients with recurrent prostate cancer may improve disease-free survival rates.

Adding Fluciclovine PET to Radiation Treatment Plans for Prostate Cancer Improves Survival

“Sexual dysfunction is an unfortunately common side effect of cancer treatment, and there appears to be a large gender disparity in how physicians discuss sexual health with their patients,” said lead study author James Taylor, MD, MPH.

Sexual Dysfunction Not Well Addressed in Female Cancer Survivors

Researchers found there has been a 17% growth in radiation therapy facilities over the last 15 years, with expansion specifically improving for those who already live near such facilities.

Access to Radiation Therapy Expands, Especially in Densely Populated Areas

This study indicated that patients with up to 3 lung metastases from primary tumors in other sites who were treated with stereotactic body radiation therapy fared comparably well whether their radiation was delivered in 1 or 4 treatment sessions.

Study Strengthens Case for SBRT Use in Oligometastatic Neoplasia to the Lung

Stereotactic body radiotherapy may be superior to conventional palliative radiotherapy in improving the complete response rate for pain related to spinal metastases at 3- and 6-months post-radiation.

SBRT Appears to be Superior to CRT for Controlling Pain Related to Spinal Metastases

When compared with whole brain radiation therapy, researchers discovered highly focused radiation therapy led to less cognitive decline while simultaneously delivering equivalent overall survival rates.

Study Suggests Stereotactic Radiosurgery Become Standard of Care for Patients with 4+ Brain Metastases

Videos

This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.

American Society for Radiation Oncology Annual Meeting (ASTRO) | Conference